Novonesis (Novozymes) A/S - Asset Resilience Ratio

Latest as of September 2025: 0.17%

Novonesis (Novozymes) A/S (NSIS-B) has an Asset Resilience Ratio of 0.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read NSIS-B total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Dkr28.19 Million
≈ $4.41 Million USD Cash + Short-term Investments

Total Assets

Dkr16.30 Billion
≈ $2.55 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Novonesis (Novozymes) A/S's Asset Resilience Ratio has changed over time. See Novonesis (Novozymes) A/S book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Novonesis (Novozymes) A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Novonesis (Novozymes) A/S.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Dkr0.00 0%
Short-term Investments Dkr28.19 Million 0.17%
Total Liquid Assets Dkr28.19 Million 0.17%

Asset Resilience Insights

  • Limited Liquidity: Novonesis (Novozymes) A/S maintains only 0.17% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Novonesis (Novozymes) A/S Industry Peers by Asset Resilience Ratio

Compare Novonesis (Novozymes) A/S's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Air Products and Chemicals Inc
NYSE:APD
Specialty Chemicals 2.49%
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
Specialty Chemicals 2.16%
Kingfa Sci&Tech Co Ltd
SHG:600143
Specialty Chemicals 0.02%
Zhongfu Shenying Carbon Fiber Co. Ltd. A
SHG:688295
Specialty Chemicals 2.48%
Arkema SA
PA:AKE
Specialty Chemicals 13.81%
Baoding Lucky Innovative Materials Co Ltd
SHE:300446
Specialty Chemicals 0.23%
Yibin Tianyuan Group Co Ltd
SHE:002386
Specialty Chemicals 0.00%
Longkou Union Chemical Co. Ltd. A
SHE:301209
Specialty Chemicals 21.72%

Annual Asset Resilience Ratio for Novonesis (Novozymes) A/S (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Novonesis (Novozymes) A/S.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.03% Dkr4.00 Million
≈ $625.83K
Dkr15.20 Billion
≈ $2.38 Billion
-0.11pp
2023-12-31 0.14% Dkr40.00 Million
≈ $6.26 Million
Dkr28.39 Billion
≈ $4.44 Billion
-0.14pp
2022-12-31 0.29% Dkr80.00 Million
≈ $12.52 Million
Dkr27.98 Billion
≈ $4.38 Billion
-0.02pp
2021-12-31 0.30% Dkr75.00 Million
≈ $11.73 Million
Dkr24.77 Billion
≈ $3.87 Billion
-0.28pp
2020-12-31 0.58% Dkr119.00 Million
≈ $18.62 Million
Dkr20.51 Billion
≈ $3.21 Billion
+0.51pp
2019-12-31 0.07% Dkr15.00 Million
≈ $2.35 Million
Dkr20.44 Billion
≈ $3.20 Billion
+0.00pp
2018-12-31 0.07% Dkr14.00 Million
≈ $2.19 Million
Dkr19.70 Billion
≈ $3.08 Billion
-0.02pp
2017-12-31 0.09% Dkr16.00 Million
≈ $2.50 Million
Dkr18.37 Billion
≈ $2.87 Billion
+0.07pp
2016-12-31 0.02% Dkr4.00 Million
≈ $625.83K
Dkr18.66 Billion
≈ $2.92 Billion
-0.09pp
2015-12-31 0.11% Dkr20.00 Million
≈ $3.13 Million
Dkr17.79 Billion
≈ $2.78 Billion
+0.02pp
2014-12-31 0.09% Dkr17.00 Million
≈ $2.66 Million
Dkr18.43 Billion
≈ $2.88 Billion
-0.43pp
2013-12-31 0.53% Dkr87.00 Million
≈ $13.61 Million
Dkr16.51 Billion
≈ $2.58 Billion
+0.23pp
2012-12-31 0.30% Dkr45.00 Million
≈ $7.04 Million
Dkr15.11 Billion
≈ $2.36 Billion
-0.05pp
2011-12-31 0.35% Dkr48.00 Million
≈ $7.51 Million
Dkr13.84 Billion
≈ $2.17 Billion
-1.07pp
2010-12-31 1.41% Dkr178.00 Million
≈ $27.85 Million
Dkr12.59 Billion
≈ $1.97 Billion
-0.81pp
2006-12-31 2.22% Dkr177.00 Million
≈ $27.69 Million
Dkr7.96 Billion
≈ $1.25 Billion
+0.16pp
2005-12-31 2.07% Dkr151.00 Million
≈ $23.63 Million
Dkr7.31 Billion
≈ $1.14 Billion
+0.76pp
2004-12-31 1.30% Dkr93.00 Million
≈ $14.55 Million
Dkr7.13 Billion
≈ $1.12 Billion
-0.20pp
2003-12-31 1.51% Dkr115.00 Million
≈ $17.99 Million
Dkr7.63 Billion
≈ $1.19 Billion
-0.48pp
2002-12-31 1.99% Dkr166.00 Million
≈ $25.97 Million
Dkr8.35 Billion
≈ $1.31 Billion
--
pp = percentage points

About Novonesis (Novozymes) A/S

CO:NSIS-B Denmark Specialty Chemicals
Market Cap
$24.39 Billion
Dkr155.92 Billion DKK
Market Cap Rank
#1065 Global
#6 in Denmark
Share Price
Dkr378.50
Change (1 day)
+1.47%
52-Week Range
Dkr342.00 - Dkr487.30
All Time High
Dkr508.57
About

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more